Connect’Innov has selected three projects for the second cohort of its CI Open Lab program, focused on innovative approaches to brain tumor management.
The projects were chosen by a jury that met on November 12. They are GICAT, led by Prof. Mehdi Touat of the Brain Institute in Paris and developed with Tunisian clinical teams; EpiGlio-RESILIENT, led by Prof. Dorra H’Mida of CHU Farhat Hached and the Faculty of Medicine of Sousse; and the NeuroBridge Translational R&D Platform, led by Mohamed Aziz Elhif of DrugIT.
According to Connect’Innov, each project will receive tailored support. EpiGlio-RESILIENT will receive a financial grant of about €10,000, while NeuroBridge will participate in BioFIT 2026, scheduled for December 10 and 11 in Marseille.
The program is supported by Servier, the Institut français de Tunisie and Caisse des Dépôts et Consignations. Connect’Innov, a Tunisia-based HealthTech support organisation, works across e-health, medtech and biotech.
Source: LinkedIn


